In recent years growth occurred in all of Teva API's principal geographical markets: North America, Europe and International.

[3] At the heart of the API division is the Israel-based Teva-Tech, formerly known as the Asia and Plantex plants which manufacture, develop and market raw materials for pharmaceuticals.

Major Teva api's acquisitions: [7] The R&D group at teva api consists of a team of over 760 top scientists located in 7 development centers worldwide: A large center in Israel (synthetic products and peptides), a large center in Hungary (fermentation and semi-synthetic products), and a facility in India and additional sites in Italy, Croatia, Mexico and the Czech Republic (development of high potency API).

[citation needed] Teva has 15 API production facilities located in Israel, Hungary, Italy, the U.S., the Czech Republic, India, Mexico, Puerto Rico, Monaco, China and Croatia.

[10] Teva api produces approximately 400 active pharmaceutical ingredients covering a wide range of products, including respiratory, cardiovascular, anti-cholesterol, central nervous system, dermatological, hormones, anti-inflammatory, oncology, immunosuppressants and muscle relaxants.